Join Us

We are 219,579 members in 84 forums discussing 161,577 topics.

Help with Abbreviations

Topic: Breaking Research News from Breastcancer.org

Forum: Clinical Trials, Research News, Podcasts, and Study Results —

Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

Posted on: Apr 16, 2012 11:33AM - edited Jan 16, 2016 01:28PM by Moderators

Moderators wrote:

Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU.

Check out this thread on a regular basis to see all the breaking news about current breast cancer research from our experts.

Get Personalized Research News Stories JUST for You!
Don't forget to fill out your profile: In the top right hand corner of the screen, under My Profile, you'll find My Diagnoses and My Treatments. Once you've provided enough information, we'll send recommended articles. Members can save these articles for later, or archive them when they're finished with them.

If you would like to receive Personalized Research News articles, based on diagnosis and treatment information, you'll need to go into "My Profile" and under the "Recommended Articles", click "turn on".

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Page 35 of 38 (1,130 results)

Posts 1021 - 1050 (1,130 total)

Log in to post a reply

Oct 1, 2019 10:54AM Moderators wrote:

Adding 2 Years of Ovarian Suppression to Tamoxifen Improves Survival in Premenopausal Women With Early-Stage Breast Cancer
September 25, 2019

Treating premenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer with tamoxifen plus 2 years of ovarian suppression after surgery offers better disease-free survival than tamoxifen alone. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 1, 2019 10:54AM Moderators wrote:

Verzenio Plus Faslodex Improves Overall Survival by 9 Months in Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
September 30, 2019

Latest results from MONARCH 2 study show adding Verzenio to Faslodex improves overall survival by 9 months for advanced-stage, hormone-receptor-positive, HER2-negative breast cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 3, 2019 11:35AM Moderators wrote:

Kisqali Plus Faslodex Improves Overall Survival in Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
October 2, 2019

Latest MONALEESA-3 results show Kisqali and Faslodex offer better overall survival than Faslodex alone in postmenopausal women diagnosed with advanced-stage, hormone-receptor-positive, HER2-negative breast cancer that either hadn't been treated yet or had been treated with only one hormonal therapy. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 3, 2019 11:36AM Moderators wrote:

Adding Keytruda to Chemotherapy Before Surgery for Early-Stage, Triple-Negative Breast Cancer Improves Response to Treatment
October 2, 2019

The combination of the immunotherapy Keytruda and chemotherapy before surgery to remove early-stage, triple-negative breast cancer led to a better pathologic complete response than chemotherapy alone. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 23, 2019 11:01AM Moderators wrote:

Multigene Testing of Everyone Diagnosed With Breast Cancer Deemed Cost-Effective, and Researchers Say Policies Should Change
October 8, 2019

A study found testing all people diagnosed with breast cancer for mutations in three genes linked to a high risk of the disease — BRCA1, BRCA2, and PALB2 — would be "extremely cost-effective" compared to testing based on family history or clinical guidelines in the United States and the United Kingdom. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 23, 2019 11:02AM Moderators wrote:

Low Vitamin D Levels Found in Irish Women Diagnosed With Breast Cancer
October 14, 2019

A small study found that more than half of Irish women being treated with chemotherapy for breast cancer had lower-than-recommended levels of vitamin D. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 23, 2019 11:03AM Moderators wrote:

Treatment of Male Breast Cancer Has Evolved, Study Shows
October 14, 2019

While there have been no clinical trials specifically focused on male breast cancer in the United States, treatment of this disease has evolved over the years and researchers now know factors linked to better survival. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 23, 2019 03:30PM Moderators wrote:

Experts Update Exercise Guidelines for People Treated for Cancer
October 23, 2019

The American College of Sports Medicine updated its guidelines on exercise for cancer prevention, as well as guidelines on exercise to ease a number of treatment side effects. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 5, 2019 12:40PM Moderators wrote:

Sentinel Lymph Node Biopsy Offers No Benefits for Older Women With DCIS
October 30, 2019

For older women diagnosed with DCIS, adding sentinel lymph node biopsy to lumpectomy didn't reduce the risk of dying from breast cancer, didn't lower the risk of being diagnosed with invasive breast cancer, and didn't reduce the number of additional cancer treatments a woman had. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Nov 5, 2019 12:41PM Moderators wrote:

CDK4/6 Inhibitor Plus Aromatase Inhibitor Helps Treat Breast Cancer, No Matter a Woman's Age
November 5, 2019

An analysis of three studies on different CDK4/6 inhibitors in combination with an aromatase inhibitor to treat postmenopausal women diagnosed with metastatic, hormone-receptor-positive, HER2-negative breast cancer found the treatment combination was effective in both younger and older women. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Dec 6, 2019 02:53PM Moderators wrote:

Supplemental MRI Screening May Benefit Women With Extremely Dense Breasts
December 3, 2019

Screening with MRI in between regular screening mammograms may improve breast cancer detection in women with extremely dense breasts. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Dec 10, 2019 01:13PM Moderators wrote:

Permanent Hair Dyes, Straighteners Linked to Higher Breast Cancer Risk
December 10, 2019

Research suggests that permanent hair dye and chemical hair straighteners could increase breast cancer risk, especially for black women. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Dec 17, 2019 02:42PM Moderators wrote:

Experimental Tucatinib Improves Survival in Metastatic HER2-Positive Breast Cancer, May Be New Standard of Care
December 17, 2019

Adding experimental tucatinib to the standard of care of Herceptin and Xeloda improved both progression-free survival and overall survival in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated with Herceptin, Perjeta, and Kadcyla. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Dec 26, 2019 04:23PM Moderators wrote:

Immunotherapy for Early-Stage Triple-Negative Breast Cancer: Understanding What Appear to Be Conflicting Results
December 19, 2019

Results from two studies on using the immunotherapy medicines Tecentriq or Keytruda along with chemotherapy to treat early-stage triple-negative breast cancer before surgery suggested that Keytruda offered benefits while Tecentriq did not. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Dec 26, 2019 04:24PM Moderators wrote:

Risk-Reducing Effects of Arimidex for High-Risk Postmenopausal Women Last Years After Treatment Stops
December 19, 2019

Postmenopausal women at high risk for breast cancer who hadn't been diagnosed continued to get risk-reducing benefits for at least 11 years after they stopped taking Arimidex preventively. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Dec 26, 2019 04:25PM Moderators wrote:

Subcutaneous Herceptin and Perjeta Combined With Chemo Before Breast Cancer Surgery Offers Same Benefits as IV Versions
December 20, 2019

A fixed-dose combination of Herceptin and Perjeta given as an injection in the thigh along with chemotherapy before surgery seems to offer the same benefits as IV infusions of the two medicines for people diagnosed with early-stage HER2-positive breast cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 9, 2020 12:45PM Moderators wrote:

Is Oral Paclitaxel Better Than IV Paclitaxel for Metastatic Breast Cancer?
January 2, 2020

Women diagnosed with metastatic breast cancer treated with an oral form of paclitaxel seemed to have a better response to treatment and less neuropathy compared to women treated with the IV version of paclitaxel. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 9, 2020 12:46PM Moderators wrote:

FDA Approves Enhertu for Unresectable or Pretreated Metastatic HER2-Positive Breast Cancer
January 2, 2020

On Dec. 20, 2019, the U.S. Food and Drug Administration approved Enhertu (chemical name: fam-trastuzumab deruxtecan-nxki) to treat people diagnosed with unresectable HER2-positive breast cancer or metastatic HER2-positive breast cancer that has been treated with two or more anti-HER2 therapies. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 9, 2020 12:46PM Moderators wrote:

Adding Perjeta to Herceptin and Chemotherapy After Surgery Shows Benefits in Early-Stage HER2-Positive Breast Cancer
January 3, 2020

Updated results show adding Perjeta to Herceptin and chemotherapy after surgery for early-stage HER2-positive breast cancer continues to reduce the risk of recurrence and to slightly improve survival. Read more..

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 9, 2020 12:47PM Moderators wrote:

Breast Cancers Found by Yearly Mammograms Smaller, Less Advanced Than Cancers Found by Mammograms Every 2 Years
January 3, 2020

Women diagnosed with breast cancer after having yearly mammograms were diagnosed with cancers that were smaller and less advanced than women who had mammograms every 2 years. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 9, 2020 12:48PM Moderators wrote:

Study Links Sustained Weight Loss After 50 to Lower Breast Cancer Risk
January 6, 2020

A study suggests that women age 50 and older who lost weight and kept it off have a lower risk of breast cancer than women whose weight remained the same. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 13, 2020 12:50PM - edited Jan 15, 2020 08:14AM by Moderators

This Post was deleted by Moderators.
Dx 6/20/2018, DCIS/IDC, Left, <1cm, Stage IA, Grade 2, 0/2 nodes, ER+/PR+, HER2+ Surgery 7/20/2018 Lumpectomy: Left; Lymph node removal: Sentinel Chemotherapy 9/5/2018 Taxol (paclitaxel) Targeted Therapy 9/5/2018 Herceptin (trastuzumab) Radiation Therapy 12/3/2018 Whole-breast: Breast Hormonal Therapy 1/5/2019 Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone)
Log in to post a reply

Jan 14, 2020 04:35PM - edited Jan 15, 2020 08:14AM by Moderators

This Post was deleted by Moderators.
Libby - Just trying to figure it all out and keep up with daily life. Dx 11/9/2017, IDC, Right, 6cm+, Stage IV, metastasized to bone, Grade 3, ER+/PR+, HER2- (IHC) Targeted Therapy 1/23/2018 Ibrance (palbociclib) Hormonal Therapy 1/23/2018 Femara (letrozole) Chemotherapy 9/14/2018 Abraxane (albumin-bound or nab-paclitaxel) Hormonal Therapy 2/11/2019 Faslodex (fulvestrant) Chemotherapy 2/12/2019 Doxil (doxorubicin) Chemotherapy 2/27/2019 Halaven (eribulin) Dx 11/6/2019, IDC, Right, Stage IV, Grade 3, ER-/PR-, HER2- (IHC) Chemotherapy 12/4/2019 Abraxane (albumin-bound or nab-paclitaxel) Immunotherapy 12/5/2019 Tecentriq (atezolizumab) Chemotherapy 3/17/2020 Ixempra (ixabepilone) Chemotherapy 3/17/2020 Xeloda (capecitabine) Chemotherapy 5/11/2020 Xeloda (capecitabine) Targeted Therapy 9/1/2020 Trodelvy (sacituzumab govitecan-hziy)
Log in to post a reply

Jan 14, 2020 05:18PM - edited Jan 15, 2020 08:20AM by Moderators

This Post was deleted by Moderators.
Dx 11/16/2017, ILC/IDC, Both breasts, 1cm, Stage IIA, Grade 2, 2/5 nodes, ER+/PR+, HER2- (FISH) Surgery 12/27/2017 Mastectomy: Left, Right Chemotherapy 1/22/2018 Cytoxan (cyclophosphamide), Taxotere (docetaxel) Hormonal Therapy 4/1/2018
Log in to post a reply

Jan 16, 2020 10:56AM Moderators wrote:

At-Home Genetic Tests Miss Many Mutations Linked to Cancer, Especially in Ethnic Minorities
January 7, 2020

At-home genetic tests are giving many people false-negative results for genetic mutations linked to breast, ovarian, and colorectal cancer. For some ethnic minorities, the risk of missing a cancer-linked mutation could be as high as 100%. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 16, 2020 10:58AM Moderators wrote:

U.S. Black Men Have Higher Rates of All Types of Breast Cancer Compared to White Men
January 7, 2020

Black men have higher rates of all types of breast cancer compared to white men in the United States. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 16, 2020 10:59AM Moderators wrote:

Taking Certain Supplements Before and During Chemotherapy for Breast Cancer May Be Risky
January 9, 2020

A small study suggests that people who took antioxidant supplements before and during chemotherapy to treat breast cancer may have a higher risk of recurrence and death. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 16, 2020 11:00AM Moderators wrote:

Long-Term Follow-Up Suggests Estrogen-Only and Combination Hormone Replacement Therapy Have Opposite Effects on Breast Cancer Risk
January 9, 2020

Estrogen-only hormone replacement therapy seems to lower breast cancer risk, while combination hormone replacement therapy increases risk, according to long-term data from the Women's Health Initiative. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 16, 2020 11:02AM Moderators wrote:

Estrogen-Receptor-Negative, Progesterone-Receptor-Positive Breast Cancers: A Distinct Subtype?
January 13, 2020

Breast cancers that estrogen-receptor-negative and progesterone-receptor-positive should be considered a distinct breast cancer subtype, according to a study. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jan 16, 2020 11:03AM Moderators wrote:

Racial Disparities in Breast Cancer Stage at Diagnosis Linked to Lack of Insurance
January 14, 2020

A large percentage of the difference in breast cancer stage at diagnosis between white women and women of other ethnicities seems to be affected by whether a woman has insurance. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...

Page 35 of 38 (1,130 results)